Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2 (HER-2) [4,5], is not sensitive to endocrine therapy or HER-2-targeted therapy. Here, ERBB2 is linked to triple-negative breast carcinoma.